Division of Pediatric Infectious Diseases
-
January 5, 2023
Three elected to the American Pediatric Society
Three physicians in the Vanderbilt Department of Pediatrics have been elected to the American Pediatric Society. -
November 17, 2022
Improving awareness and understanding of antimicrobial resistance is crucial
The Vanderbilt Antimicrobial Stewardship Program provides oversight of antimicrobial therapies for both inpatient and outpatient populations. -
November 4, 2022
Study finds Moderna’s COVID-19 vaccine safe and effective for young children
A Vanderbilt study finds that Moderna’s COVID-19 vaccine is safe and effective in children 6 months to 5 years of age. -
November 3, 2022
Event to spotlight VUMC’s COVID-19 research efforts
The public is invited to listen in as scientists on the forefront of COVID-19 research at Vanderbilt University Medical Center share their personal stories on Wednesday afternoon, Nov. 16, in 214 Light Hall. -
September 7, 2022
VUMC study will evaluate alternative strategies for administering mpox vaccine
Rarely fatal, the mpox virus — spread by close, often skin-to-skin contact — causes a painful, blistering rash, fever, chills and other symptoms. -
August 25, 2022
Vanderbilt researchers discover how gut inflammation leads to bone loss
Gastrointestinal inflammation, such as occurs in inflammatory bowel disease, triggers the expansion of a population of “bone-eating” cells, leading to bone loss. -
August 16, 2022
Q&A: Reassurance for parents on mpox risk, spread and symptoms
A pediatric infectious diseases expert answers questions parents might have about the risk of mpox risk to children.